Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD Following recent approvals in the EU, China, and the US, this approval was based on pivotal phase 3 results in ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils Approval marks the first new treatment approach for ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD Following recent approvals in the EU, China, and the US, this approval was based on pivotal phase 3 results ...

FAMU-FSU College of Engineering researchers have created a new method for studying protein degradation within immune cells ...

The formulation comparison between a biosimilar and a branded biologic. The cost, availability, and supply chain benefits of ...

It may be disturbing to characterize human bodies in such commodifying terms, but the unavoidable reality is that human ...

By incorporating healthspan science into clinical practice, some doctors are navigating a gray area between mainstream ...

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

Effective models could unlock some of what is still unknown in biology and help your doctor find the right treatment.

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended ...

At the foundation of healthspan medicine are the pillars of health. These are easily understood through four simple verbs: ...

A study in Science Translational Medicine found when patients take the drug nitisinone, their blood becomes deadly to ...